Receptor simulation and the shape of the concentration-response curve and its congeners

 

Show simple item record

dc.contributor.author Cridland, J.S.
dc.contributor.author Witten, G.Q.
dc.date.accessioned 2016-01-04T14:01:36Z
dc.date.available 2016-01-04T14:01:36Z
dc.date.issued 2003
dc.identifier.citation Cridland, J. S., & Witten, G. (2003). Receptor simulation and the shape of the concentration-response curve and its congeners: News and views. South African Journal of Science, 99 (7&8), p. 302-303. en_ZA
dc.identifier.issn 0038-2353 en_ZA
dc.identifier.uri http://hdl.handle.net/11427/16201
dc.description.abstract We have investigated the utility of curves used to represent concentration (or dose) plotted against response (or effect). We applied crude survival data from our laboratory to demonstrate that a known hyperbolic curve compares favourably with the conventionally used sigmoidal regression in robustness, while avoiding problems associated with the use of transforms. en_ZA
dc.language eng en_ZA
dc.publisher Academy of Science of South Africa (ASSAf) en_ZA
dc.rights Creative Commons Attribution 4.0 International (CC BY 4.0) *
dc.rights.uri http://creativecommons.org/licenses/by/4.0/ en_ZA
dc.source South African Journal of Science en_ZA
dc.source.uri http://www.sajs.co.za/
dc.title Receptor simulation and the shape of the concentration-response curve and its congeners en_ZA
dc.type Journal Article en_ZA
dc.date.updated 2016-01-04T13:39:54Z
uct.type.publication Research en_ZA
uct.type.resource Article en_ZA
dc.publisher.institution University of Cape Town
dc.publisher.faculty Faculty of Health Sciences en_ZA
dc.publisher.department Division of Clinical Pharmacology en_ZA
uct.type.filetype
uct.type.filetype Text
uct.type.filetype Image


Files in this item

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International (CC BY 4.0) Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International (CC BY 4.0)